Get access to our best features
Get Started
Subscribe
Israeli-Palestinian Conflict
Earth Day
2024 US Election
US Politics
Donald Trump
US Economy
Baseball
Joe Biden
Republican Party
US Crime
US Social Issues
Senate
Housing
Get access to our best features
Get Started
Published 3 years ago

MD Anderson researchers highlight advances in clinical studies at the AACR Annual Meeting 2021

Summary by Eurek Alert
(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas MD Anderson Cancer Center conducted early phase clinical trials that showed promising results for patients with RET fusion-positive cancers, high-grade and low-grade glioma and ovarian cancer. The results for these studies will be presented at the AACR Annual Meeting 2021.

0 Articles

All
Left
Center
Right
Eurek AlertEurek Alert

MD Anderson researchers highlight advances in clinical studies at the AACR Annual Meeting 2021

(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas MD Anderson Cancer Center conducted early phase clinical trials that showed promising results for patients with RET fusion-positive cancers, high-grade and low-grade glioma and ovarian cancer. The results for these studies will be presented at the AACR Annual Meeting 2021.

3 years ago·Washington, United States
Read Full Article
Business WireBusiness Wire

BeiGene Presents Clinical Data on Sitravatinib in Combination with Tislelizumab at the AACR Annual Meeting 2021

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines wor

3 years ago·Crystal River, United States
Read Full Article
Globe NewswireGlobe Newswire

PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021

PC14586 selectively stabilizes the p53 Y220C mutant and restores p53 activityRobust in vivo tumor regression observed with once daily oral...

3 years ago
Read Full Article
The Market HeraldThe Market Herald

Imugene (ASX:IMU) presents key findings to leading cancer research association - The Market Herald

Imugene (ASX:IMU) presented key findings from its HER-Vaxx immunotherapy and CF33 oncolytic virus programs at the American Association for Cancer Research's annual meeting.

3 years ago
Read Full Article
PressNewsAgencyPressNewsAgency

Intellasia East Asia News – BeiGene Presents Clinical Data on Sitravatinib in Combination with Tislelizumab at the AACR Annual Meeting 2021

The combination showed preliminary antitumor activity in patients with unresectable or metastatic melanoma refractory or resistant to PD-1/L1 inhibitors and platinum-resistant ovarian cancer in an …

3 years ago
Read Full Article
AACR NewsAACR News

Elite group to receive AACR scientific achievement awards and lectureships

The American Association for Cancer Research will honor several cancer researchers, physician-scientists, advocates, and policymakers for their achievements during the Annual Meeting.

3 years ago
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

MedicalMedical
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal